StockData
Crescent Biopharma, Inc. logo

Crescent Biopharma, Inc. (CBIO) stock

CBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$13.04−0.46 (-3.41%)

Close on Nov 17, 2026Market cap $484.36MP/E –Yield –

Crescent Biopharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Crescent Biopharma's market cap was $409.54M on Nov 11, 2026, against $209.08M a year earlier. Over the last 5 years it ranged from $21.39M to $19.32B, with a median of $2.64B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$409.54M+148.6%
2025Dec 31, 2025$164.77M-89.8%
2024Dec 31, 2024$1.61B-89.4%
2023Dec 29, 2023$15.19B-4.4%
2022Dec 30, 2022$15.88B+113.2%
2021Dec 31, 2021$7.45B-58.6%
2020Dec 31, 2020$17.98B-21.6%
2019Dec 31, 2019$22.94B-43.9%
2018Dec 31, 2018$40.85B-25.7%
2017Dec 29, 2017$54.97B+290.7%
2016Dec 30, 2016$14.07B+29.2%
2015Dec 31, 2015$10.89B-20.0%
2014Dec 31, 2014$13.60B–

More Crescent Biopharma figures

See a number that looks wrong?